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ReleaseThiswork proposes to combine tranexamic acid (TAX), a clinically used antiﬁbrinolytic agent, and hydroxyapatite
(HA),widely used in bone replacement, to produce a novel bioactive apatitic biomaterial with intrinsic hemostat
ic properties. The aim of this study was to investigate adsorptive behavior of the TAX molecule onto HA and to
point out its release in near physiological conditions.
No other phase was observed by X ray diffraction or transmission electronmicroscopy, and no apparent change
in crystal size was detected. The presence of TAX on the powders was lightly detected on Raman spectra after ad
sorption. The adsorption data could be ﬁtted with a Langmuir Freundlich equation, suggesting a strong interac
tion between adsorbed molecules and the formation of multilayers. The concentration of calcium and phosphate
ions in solution remained low and stable during the adsorption process, thus ion exchange during the adsorption
process could be ruled out. The release of TAXwas fast during the ﬁrst hours andwas governedby a complex pro
cess that likely involved both diffusion and dissolution of HA. Preliminary aPTT (activated partial thromboplastin
time) hemostasis tests offered promising results for the development of osteoconductive apatitic biomaterials
with intrinsic hemostatic properties, whether for dental or orthopedic applications.1. Introduction
Orthopedic, dental, and trauma surgeries are accompanied, among
others, by a high risk of bleeding, and uncontrolled hemorrhage can
be the leading cause of blood transfusions, morbidity, and mortality.
Blood transfusionsmay be a life savingmeasure in such cases, but it re
mains an expensive resource and can result in a variety of problems for
patients like the risk of infection transmission.
Hemostasis is deﬁned as “the stoppage of bleeding.” The threemajor
steps of hemostasis are 1.) vasoconstriction, which diminishes blood
loss; 2.) exposure of collagen, which initiates a series of reactions called
the coagulation cascade on the wall of blood vessels, leading to the for
mation of a primary hemostatic plug; andﬁnally, 3.) adhesion of platelets
onto the blood vessel wall, leading to the conversion of ﬁbrinogen into
ﬁbrin to create the ﬁnal clot [1]. Effective and rapid hemostasis is critical
to optimize surgical outcomes. In this context, hemostatic agents are ad
juvants used in surgery to improvehemostasiswhen conventional tech
niques (clips, staples, sutures, ligatures, and electrocoagulation) are
insufﬁcient [2]. Various hemostatic drugs have thus been used and
show some efﬁcacy in many types of surgery [3].PS, Université de Toulouse,
030 Toulouse Cedex 04, France.
.Tranexamic acid [trans 4 (aminomethy1) cyclohexanecarboxylic
acid, TAX] is a clinically used antiﬁbrinolytic agent (Fig. 1). It is a synthetic
lysine analog and is used to manage of different bleeding disorders as
well as to reduce postoperative blood loss in patients undergoing high
bleeding risk surgeries. The hemostatic property of TAX mainly relates
to its ability to inhibit the conversion of plasminogen to plasmin, thereby
preventing excessive blood loss in hyperﬁbrinolytic conditions. Plasmin
breaks down ﬁbrinogen and a series of other proteins involved in coagu
lation [3,4]. TAXhowever presents a lowbioavailability of only 30 50%by
oral administration [5]. In orthopedic surgery such as knee or hip
arthroplasty, TAX appears to be more efﬁcacious when a dose of
N30 mg/kg is used [4]. Moreover, it has been found to cause gastrointes
tinal side effects when administered orally, whereas this has not been re
ported with intravenous administration. However, rapid intravenous
boluses may cause hypotension, so it is recommended that it is given ei
ther over 10min or via infusion, although its dose needs to be reduced in
cases of renal impairment. Thus, especially for surgical procedures known
to present a high risk for bleeding, the search for improved hemostasis
approaches or methodologies is still undergoing.
One appealing approach when dealing with bone related surgeries
is to confer hemostatic properties to the implanted biomaterial itself.
Calcium phosphates with an apatitic structure (apatites) constitute
the mineral part of calciﬁed tissues such as bone and teeth [6] and are
for this reason widely used for bone related biomedical applications,
Fig. 1. Tranexamic acid (TAX).in various forms including powders, scaffolds, self setting cements, or
coatings [7,8]. Surface functionalization of apatite crystals with biomol
ecules of biological interest (e.g., growth factors, drugs, enzymes, etc.)
also increases its potential for medical uses: for example, in the ﬁeld
of bone repair, for activating bone tissue regeneration, for limiting oste
oclastic resorption, or preventing bone infections. Due to their excep
tional surface reactivity, apatitic compounds have been widely studied
with drug delivery objectives [9]. Adsorption on apatitic surfaces (as op
posed to simple impregnation) leads to a stable association and control
of the amount of bioactive molecules associated in the solid implant,
and thus of the dose released, that increase its potential for the develop
ment of osteoconductive biomaterials with drug delivery properties
[10]. Also, the understanding of biomineralization events involves a bet
ter comprehension of biomolecules adsorption phenomena. For in
stance, several bone proteins such as osteocalcin, osteopontin, as well
as biomolecules including albumin, or else phospholipids, among
others, have been shown to adsorb strongly onto apatite [11,12]. In
the biomaterials ﬁeld, some bone adsorbing molecules used in the
treatment of bone diseases, like bisphosphonates, have been used to
control bone turnover and their biological activity has been shown to
correlate with their adsorption properties [9]. The surface characteris
tics of apatites are also largely used in separation chromatography of
proteins, and in fact, preparatory and development studies for these ap
plications have initiated research on adsorption on apatite surface [13].
Among the calcium phosphate compounds widely used nowadays in
bone replacement, stoichiometric hydroxyapatite (HA, Ca10(PO4)6(OH)2)
is the most commonly found. The aim of this work was to combine TAX
and hydroxyapatite to produce a novel bioactive apatitic biomaterial
with intrinsic hemostatic properties. Such biomaterials may be used in
orthopedic or dental surgery to control blood loss while avoiding the ad
verse effects of systemic medication. The adsorption of TAX on HA could
allow controlling the release of the hemostatic drug. Thus, the aim of this
study was in priority to investigate the adsorptive behavior of TAX onto
HA and to point out its release in near physiological conditions. Full char
acterizations of the powders before and after adsorption were also per
formed to better understand the mechanism of adsorption.2. Materials and methods
2.1. Materials
Stoichiometric hydroxyapatite (HA) was synthesized by double de
composition by adding dropwise a phosphate salt aqueous solution
(1.54 M (NH4)2HPO4, 433.3 mL) into a calcium salt aqueous solution
(1 M Ca(NO3)2.4H2O, 1100 mL) at 90 °C under continuous stirring
[14]. The pH of the suspension during the synthesis was approximately
10 by adding NH4OH. After ﬁltration, the precipitate was washed andfreeze dried. The powder obtained was sieved (b125 μm) and stored
in a freezer.
The phosphate content in the HA sample was determined by
spectrophotometry using the phosphovanadomolybdic acid complex
method and the calcium content was measured by complexometry
with EDTA (relative error of 0.5%) [15]. The determination of the atomic
Ca/P ratio of the precipitate was reached with a relative error of 1%. The
speciﬁc surface area of the powder was determined by nitrogen adsorp
tion according to the Brunauer Emmett Teller (BET) method with a
Quantachrome Instruments Monosorb NOVA 1000.
Powder of tranexamic acid (trans 4 (aminomethy1)cyclohexanecar
boxylic acid, TAX) was obtained from Sigma Aldrich (purity 97%). Cis
4 (aminomethyl)cyclohexanecarboxylic acid was used as the internal
standard (IS) for TAX titration and was purchased from Sigma Aldrich
(purity 95%).
2.2. Adsorption experiments
Adsorption experiments were performed in 1 mM potassium chlo
ride aqueous solution of TAX (initial concentration varied from 0 to
6 g/L or 3.8 × 10−2 M). 50 mg of the HA sample was dispersed in
5 mL of the adsorption medium in a polypropylene tube and sonicated
for a fewminutes (initial pH about 7.2). Preliminary tests demonstrated
that the kinetics of adsorption of TAX on HA was slow; therefore, the
suspensions obtained were incubated in the presence of TAX for 24 h
(without stirring and at ambient temperature). After incubation, the ad
sorption tubes were centrifuged for 20 min at 5000 rpm. The resulting
supernatants were ﬁltered through Millipore ﬁlters (pore size 0.2 μm)
and analyzed for calcium and phosphate titrations. The solids (HA
TAX) retrieved after adsorptionwere freeze dried and stored in a freez
er before characterization. Blanks containing only the adsorption solu
tion incubated without solid were used as controls.
2.3. Solution analysis
Phosphate and calcium levels in the supernatants were determined
by Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP
OES, Horiba Jobin Horibo).
There is no chromophore in the TAX molecule enabling direct anal
ysis by UV visible spectrophotometry. Therefore, TAX was titrated in
solution using a liquid chromatography/mass spectrometry (LC/MS)
method previously adapted from Grassin et al. [16]. Chromatographic
separationwas performed on a 6140 Quadrupole 1200 Series LC system
using an Uptisphere® Strategy™ C18 2 Column (5 μm, 4.6 × 150 mm,
Agilent Technologies). The mobile phase was prepared by adjusting
formic acid solution (0.1%) and methanol in the ratio 48:52 (v/v). The
ﬂow rate was 5 μL/s, the run time was equal to 4 min and the injection
volumewas 10 μL. A peakwas observed at 2.29min for TAX and 2.30 for
IS. Amass spectrometer, equipped with an electrospray ionization (ESI)
source was used for detection and quantiﬁcation.
Stock solutions of TAX (1 g/L) and of the internal standard (IS,
0.4 g/L) were prepared separately in ultra pure water. TAX (from 0 to
12 ppm) and IS (5 ppm) calibration samples were prepared in triplicate
by dilution of their stock solutions in ultra pure water. The calibration
curve (Fig. 2) was obtained by plotting the peak area ratio of TAX to IS
(TAX/IS) as a function of TAX concentration. The calibration equation
was obtained by linear regression analysis (r2 = 0.9997).
2.4. Release kinetics
TAX release proﬁles were obtained with a ﬂow through cell system
(USP Apparatus 4, Sotax AG, Switzerland) with a ø=12mmcell (6mL)
and a piston pump(SotaxCY, SotaxAG, Switzerland). Release testswere
performed at 37.0 ± 0.5 °C under sink conditions according to the
European Pharmacopoeia guidelines [17]. The dissolution medium
consisted of ultra pure water pumped through the column at a ﬂow
Fig. 2. Calibration curve of tranexamic acid by LC/MS method.rate of 15 mL/min and the closed system consisted of 50 mL of recycled
dissolution medium. In all experiments, laminar ﬂow was used with a
bed of 1 g of glass beads covered with 100 mg of HA powder after TAX
adsorption (175 μmol TAX/g HA).
Periodically, 5 mL of dissolution mediumwas collected and ﬁltrated
throughMillipore ﬁlters (pore size 0.2 μm) and the TAX contentwas de
termined by LP MS (25 samples from 5 to 2100min). The same volume
of dissolution medium was replaced back after each sampling in order
to maintain a constant volume and remain in sink conditions. Each re
lease test was duplicated. The results are presented as kinetics of cumu
lative TAX release (in %) as a function of time:
TAX released% Qr cumul=Qadsð Þ  100 ð1Þ
where Qr cumul is the cumulative amount of TAX released and Qads is the
initial quantity of TAX adsorbed.
2.5. Characterization of solids after adsorption
The solid phases before and after TAX adsorption were characterized
by X ray diffraction (XRD), using an Equinox 1000 curved counter
INEL diffractometer with a cobalt anticathode (λCo = 1.78892 Å).
Raman microspectroscopy analysis was performed using a confocal
microspectrometer (Horiba Jobin Yvon Labram HR800) with a heliumFig. 3. (a) X-ray diffraction pattern of the powder sample after adsorption (HA-TAX) and i
observations of the powders (b) before (HA) and (c) after adsorption (HA-TAX), (175 μmol TAneon laser (λ = 632.82 nm) over a wavenumber range of 350
1750 cm−1. Transmission electron microscopy (TEM) micrographs
were obtained on a JEOL JEM 2100F microscope set at an acceleration
tension of 200 kV.
2.6. Hemostasis tests
Preliminary hemostatic tests were carried in this work bymeasuring
the activated partial thromboplastin time (aPTT), which is a global
screening assay to evaluate the coagulation cascade. The aPTT is the
clotting time obtained when “partial thromboplastin” is added to plas
ma. Partial thromboplastin is the phospholipid fraction of a tissue ex
tract and differs from a complete tissue extract (i.e., “thromboplastin”)
by the lack of tissue factor [18,19].
Blood specimens from 10 healthy adult dogs of various breeds were
obtained by jugular venipuncture, using minimal restraint and hand
compression. Blood specimenswere drawn using a 0.8 × 25mmneedle
(Neolus; Terumo Europe N.V., Leuven, Belgium) connected to a vacuum
system (VenojectLuer adapter; Terumo Europe, N.V.) into a citrated
tube (Venosafe; Terumo France, Guyancourt, France). Trisodium citrate
(0.129M) is a good calcium ligand, and in the ratio 1:9 (v/v), the decal
ciﬁcation prevents clot formation.
To examine the effect of two solid samples on the aPTT, 50 mg HA
with and without adsorbed TAX (175 μmol TAX/g HA) was added to
1.2 mL of citrated whole blood, and the results were compared with
the results obtained when only TAX was added (100 μL TAX in aqueous
solution, 1 g/L). Citrated plasmas were then obtained after centrifuga
tion of the blood specimens for 5 min at 2900 g (Hettich Rotoﬁx 32 A,
Tuttlingen, Germany).
aPTT was automatically measured using a STA Compact analyzer
(Diagnostica Stago, Asnières sur Seine, France) after quality control
using STA Coag Control N + P (Diagnostica Stago, Asnières sur Seine,
France). Brieﬂy, citrated plasmawas incubated at 37 °Cwith anactivator
and phospholipid (partial thromboplastin). CaCl2 was then added to
start the coagulation cascade. Results are expressed in seconds, as the
time taken for aﬁbrin clot to form. Each testwasperformed in duplicate.
3. Results and discussion
3.1. Characterization of powders
The synthesized HA sample had a Ca/P molar ratio of 1.66 ± 0.02
corresponding to stoichiometric hydroxyapatite (Ca10(PO4)6(OH)2).
The speciﬁc surface area of HAwas 58 (±3)m2/g. The solids were char
acterized after adsorption. Its X ray diffraction pattern displayed char
acteristic diffraction lines of well crystallized hydroxyapatite and nondexation of the main diffraction lines in relation with JCPDS ﬁle ref. no.09–432. TEM
X/g HA).
Fig. 4. Raman spectra of the samples before (HA) and after (HA-TAX) adsorption of tranexamic acid (TAX), (175 μmol TAX/g HA).
Fig. 5. Adsorption isotherm of TAX on HA at 37 °C.other crystalline phase was detected after TAX adsorption (Fig. 3a);
these results were further conﬁrmed by TEM. Furthermore, there was
no apparent change in crystal size, as all crystals remained approxi
mately 100 nm in length (Fig. 3b and c).
Raman spectra of the powders before (HA) and after (HA TAX) ad
sorption are presented in Fig. 4 and compared with the Raman spectrum
of pure TAX. Raman spectra of the solids showed characteristic lines of
apatitic phosphate groups: ν1 (960 cm−1), ν2 (430 450 cm−1), ν3
(1040 1074 cm−1), and ν4 (580 608 cm−1) modes of PO43− [20]. More
over OH− apatitic vibration was also detected around 3560 cm−1. Char
acteristic vibration bands corresponding to TAX around 1500 cm−1
(νC\\C, νC O, νCH2, νNH2), and between 2800 and 3000 cm−1 (νCH2,
νCH), were slightly detected beside the HA spectrum after adsorption,
probably because the amount of adsorbed TAX was limited and also be
cause TAX molecule exhibits Raman vibration bands of low intensity.
3.2. Adsorption of tranexamic acid
The evolution of the amount of TAX adsorbed, Qads (μmol/m2), onHA
from dilute aqueous solutions (0 40mM) as a function of its remaining
concentration in solution, Ceq (mmol/L), is plotted in Fig. 5. As shown in
the graph, no adsorption plateau was observed as the general tendency
was a continuous increase of the adsorbed amount versus Ceq.
The adsorption of (bio)molecules with a strong afﬁnity for apatite
surfaces can often be described by the Langmuir isotherm [9]. This is
the case for example for some biomolecules exhibiting phosphate or
phosphonate endgroups as in phosphoserine or bisphosphonates. In
this model, the solid surface is considered to be composed of energeti
cally equivalent adsorption sites and no interaction exists between ad
sorbate molecules [21,22] that form a monolayer on the surface of the
substrate. Also, the adsorption of molecules exhibiting a high afﬁnity
for apatitic supports is often accompanied by a simultaneous ion ex
change process, involving ions such as phosphate anions from thesurface of apatite crystals. When the amount adsorbed on apatitic sur
faces is small, the adsorption is generally more accurately described
by the Freundlich model. This is the case for molecules such as glycine,
acetic acid, or else serine [9,22]. Such molecules weakly interact with
apatite surface due to the presence of endgroups that have only a low
afﬁnity for apatite surface, such as carboxylate. However, the present
data give graphical evidence that TAX adsorption on HA cannot be de
scribed by the Langmuir isotherm model or the Freundlich model. In
deed, rather than a tendency toward stabilization, an increasingly
greater adsorption versus Ceq is observed here. This evolution reminds
a power law. Indeed, a mathematical analysis of the adsorption data
Fig. 6.Mechanism proposed for adsorption of TAX on the (001) surface plane of HA (using Crystalmaker and ChemDraw Softwares).
Fig. 7. Concentration of phosphate (blue squares) and calcium (red circles) ions in the
solutions after adsorption upon Qads of TAX on HA.showed that the curve can be satisfactorily (r2= 0.994) described by an
equation of the form:
Qads K  Ceqn ð2Þ
with a value of “n” N 1, namely n= 1.99 ± 0.11, and K = 2.64 ± 0.41
(with Qads in μmol/m2 and Ceq in mmol/L). Note that this equation
should not be confounded with the one describing the typical
Freundlich model which has an equivalent form but with an exponent
“n” lower than 1.
At this point, it was also interesting to check how the adsorption
data could mathematically be ﬁtted with a Langmuir Freundlich equa
tion, also known as Sips, which also affects an exponent to the equilib
rium concentration, as in the equation:
Qads Nm 
K  Ceq
 n
1þ K  Ceq
 n ð3Þ
(Note that there exists also an equivalent form of this equation that
replaces Kn with the constant KS). The mathematical treatment of the
data showed that such an equation could indeed describe the evolution
Fig. 8. Kinetics of release of TAX (%) from HA after adsorption. The amount of initial
concentration of TAX was equal to Qads (TAX) = 175 μmol/g HA.of Qads versus Ceq in the case of TAX adsorption on hydroxyapatite, with
a correlation coefﬁcient of r2 = 0.999, and the parameters n= 2.98 ±
0.16, K = 0.032± 0.002 L/mmol, and Nm= 11.85± 1.14 μmol/m2. Ac
cording to the Langmuir Freundlich theory, departure from an ideal ad
sorption situation as depicted by Langmuir arises from the existence of
surface heterogeneities with non equivalent sites and/or of non
negligible interactions between adsorbed species. As previously men
tioned in the literature, an exponent n N 1 suggests the existence of pos
itive cooperativity between adsorbed molecules. Taking into account
the shape of the isotherm observed here, the formation of multilayer
of adsorbed molecules seems to be highly probable. The adsorbed
amounts reached on the adsorption isotherm (Fig. 5) and by Nm value
were both particularly high for molecules that do not expose high
afﬁnity groups for the surface of apatite surfaces. Indeed, only one car
boxyl and one amino group are present on the TAX molecule, which
present relatively low afﬁnity for the surface of the apatite, as has
been previously reported for example for the amino acid serine [22].
This was particularly true for the present apatite sample, which is stoi
chiometric and well crystallized, thus affected by a limited surface reac
tivity. In contrast, the adsorption of molecules such as bisphosphonates,
for example, which exhibit high afﬁnity phosphonate groups, led to
maximum amounts adsorbed of approximately 3 μmol/m2 on apatitic
substrates [21]. The high adsorbed amounts observed here can only be
explained by the formation of TAXmultilayers, withmolecules probably
interacting with each other through respectively their\\COO− and
\\NH3+ terminal groups. This is consistent with the exponent value
foundwith the Langmuir Freundlichmodel, suggesting a strong impact
of intermolecular interactions rather than interactions with the surface
of the nanocrystals. This is also consistent with the equilibriumFig. 9. Linear regression of (a)Korsmeyer–Peppasmodel (Release TAX%=KKP× tn,with KKP con
with KHC constant and QR the quantity of TAX released from HA) for the release kinetics of TAXdissociation constants of TAX from the literature (the pKa for carboxylic
acid and amine functional groups in TAX were estimated to be 4.9 and
10.6, respectively [16]). The mechanism of interaction of TAX with HA
could tentatively be then proposed in two steps: (1) TAX carboxyl
groups interact with calcium ions on the surface of HA to form a mono
layer on the apatitic support, and simultaneously (2) interaction be
tween protonated amino groups and carboxyl species between
adsorbate molecules of TAX leads to the formation of multilayers (Fig.
6). Note that the data were also tentatively ﬁtted to other isotherm
models often used to describe multilayer adsorption, including on
solid samples, like the BET isotherm [23]. Although a moderately good
ﬁt was reached (r2 = 0.983), the Langmuir Freundlich still remained
the best model to ﬁt the experimental data.
3.3. Mineral ion composition of solutions after adsorption
The change in the mineral content of the solution is shown in Fig. 7.
Note that there was no signiﬁcant change in the pH of the solution dur
ing the adsorption experiments (pH remained close to 7.4). The data
point related to a Qads equal to zero corresponded to a blank assay per
formed under the same conditions as the adsorption experiments in the
absence of TAX. The calcium and phosphate ion content in the solution
remained low (corresponding to low solubility of the HA substrate) and
most importantly stable during the adsorption process, at approximate
ly 0.15 and 0.05mM, respectively, for calcium and phosphate. The min
eral ion content in the solution therefore did not seem to be related to
the amount of TAX adsorbed and was only due to the congruent disso
lution of the crystals in aqueous solution as the Ca/P ratio in solution
was the same as in the solid (i.e. Ca/P ~ 1.66). Therefore, the possibility
of ion exchange occurring during the adsorption process can be ruled
out, contrary to the case of several (bio)molecules with a strong afﬁnity
for the surface of apatites, as mentioned above.
3.4. Release kinetics
The kinetics of release of TAX (in %) fromHA are shown in Fig. 8. The
release was initially fast, as 20% of TAXwas released during the ﬁrst 6 h.
Then TAX release slowed down, impacted by the dissolution of HA but
not only. By linearization using different models, some linear zones
can be pointed out allowing us to conclude that the release mechanism
was probably governed by a complex process involving both diffusion
(as in Korsmeyer Peppas model for example) and dissolution (as in
Hixson Crowell model), as suggested by Fig. 9 [24,25].
3.5. Preliminary hemostasis results via aPTT evaluations
aPTT results are presented in Fig. 10. With regards to the solid sam
ples, the aPTT of HA powders decreased for each specimen with the
presence of adsorbed TAX. This can be clearly visualized by the lower
position of the HA/TAX curve (red circles) as comparedwith theHA sub
strate alone (black squares).stant et n thediffusion parameter) and (b)Hixson–Crowellmodel ( Q3
p
ads Q3
p
R=KHC× t
from HA.
Fig. 10. aPTT obtained for the powders of hydroxyapatite before (HA) and after adsorption
(HA/TAX with Qads (TAX) = 175 μmol/g HA), and for TAX solution (1 g/L) performed on
ten healthy adult dogs.Note that the data points corresponding to free TAX (blue triangles)
relate to a solution while apatitic samples (HA and HA/TAX) were solids;
therefore, the dilution of TAXduring aPTT experiments prevented adirect
comparison with the powder samples.
Although preliminary, these results point out a reduction in aPTT;
this is extremely promising for the development of apatitic biomaterials
with intrinsic hemostatic properties.
4. Conclusion
The aim of this work was to combine tranexamic acid (TAX), a clini
cally used antiﬁbrinolytic agent, and hydroxyapatite (HA) widely used
in bone replacement, to produce a novel bioactive apatitic biomaterial
with intrinsic hemostatic properties. The study of the adsorptive behav
ior of the TAX molecule onto HA was performed and its release in near
physiological conditions was also followed. When the isotherm of ad
sorption of TAX onto the HA surface was plotted, no adsorption plateau
was observed as the general tendency was a continuous increase of the
adsorbed amount. Despite the low afﬁnity of TAX for the surface of HA
crystals, likely due to the presence of only a carboxyl and an amino
group known to have a relatively low afﬁnity for the surface of apatite,
signiﬁcant adsorbed amounts could be reached: the adsorption data ex
hibited an exponential tendency mathematically ﬁtted to a Langmuir
Freundlich equation with an exponent close to 3. This suggested a
strong interaction between adsorbedmolecules, resulting in the forma
tion of multilayers. This tendency may be an advantage in practical he
mostasis applications for potentially transporting large doses of TAX
directly to the bleeding wound site for increased efﬁciency. Further
more, it may be useful for adapting the dose of TAX to the condition of
the patient (evaluation of bleeding risk, possible hemophilic condi
tions…). The concentration of calcium and phosphate ions in solutionremained low and stable during the adsorption process, thus ion ex
change during the adsorption process can be ruled out. The release of
TAXwas fast during theﬁrst hours andwas governed by a complex pro
cess that likely involved both diffusion and dissolution of HA. The pre
liminary hemostasis aPTT tests on the blood from ten healthy adult
dogs showed promising results for the development of apatitic bioma
terials with intrinsic hemostatic properties. Especially for surgical pro
cedures known to present a high risk for bleeding, the search for
improved hemostasis approaches or methodologies is still undergoing.
One appealing approach when dealing with bone related surgeries is
to confer hemostatic properties to the implanted biomaterial itself,
and apatitic biomaterials appearwell suited for this goal. Thiswork con
siders the possibility to develop apatitic based bone repair biomaterials
with hemostatic activity and the preliminary results obtained are prom
ising. This contribution can thus be seen as a ﬁrst approach for the de
velopment of osteoconductive and hemostatic biomaterials, which
may be optimized in the future by the use of apatite nanoparticles
allowing higher adsorbed amounts of drugs thanks to their larger spe
ciﬁc surface areas and surface reactivity than HA, for further improving
drug delivery properties.References
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